Cagrilintide D

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

ObesityOverweight

Phase 1

A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity

RecruitingNCT07597018

Novo Nordisk A/SObesity, Overweight

Start: 2026-05-18End: 2027-06-01Target: 234Updated: 2026-06-26

A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight

CompletedNCT07605052

Novo Nordisk A/SObesity, Overweight

Start: 2026-05-20End: 2026-08-19Updated: 2026-09-04